Skip to main content
Toggle navigation
Search
Home
Full Schedule
All Days
Fri, Sep 25
Sat, Sep 26
Sun, Sep 27
Mon, Sep 28
Tue, Sep 29
Full Schedule
Type here to filter the list
Sunday, September 27, 2026
6:30 AM - 5:00 PM
EDT
ACCP Registration Open
6:30 AM - 5:00 PM
EDT
ACCP Registration Open
7:00 AM - 7:45 AM
EDT
Continental Breakfast
7:00 AM - 7:45 AM
EDT
Continental Breakfast
7:00 AM - 7:45 AM
EDT
New Member & First-time Attendee Welcome
7:00 AM - 7:45 AM
EDT
New Member & First-time Attendee Welcome
7:00 AM - 7:45 AM
EDT
Student, Trainee & Early-stage Professional (STEP & ESP) Welcome
7:00 AM - 7:45 AM
EDT
Student, Trainee & Early-stage Professional (STEP & ESP) Welcome
7:00 AM - 7:00 PM
EDT
Exhibit Hall Open
7:00 AM - 7:00 PM
EDT
Exhibit Hall Open
7:45 AM - 8:00 AM
EDT
Welcome & Opening Remarks by ACCP President
7:45 AM - 8:00 AM
EDT
Welcome & Opening Remarks by ACCP President
8:00 AM - 9:30 AM
EDT
Opening Plenary Session
Co-Chair & Faculty:
Lisa von Moltke, MD
Co-Chair & Faculty:
Mary Jimenez, BBA
– Alamo Breast Cancer Foundation
Novel Mechanisms & Emerging Therapeutic Modalities
CE: 1.5
8:00 AM - 9:30 AM
EDT
Opening Plenary Session
Co-Chair & Faculty:
Lisa von Moltke, MD
Co-Chair & Faculty:
Mary Jimenez, BBA
– Alamo Breast Cancer Foundation
Novel Mechanisms & Emerging Therapeutic Modalities
CE: 1.5
8:00 AM - 9:30 AM
EDT
1 - Opening Plenary Session: Navigating Novel Therapeutic Modalities
Chair & Faculty:
Lisa von Moltke, MD
Novel Mechanisms & Emerging Therapeutic Modalities
8:00 AM - 9:30 AM
EDT
2 - Opening Plenary Session: Navigating the Patient Perspective
Co-Chair & Faculty:
Mary Jimenez, BBA
– Alamo Breast Cancer Foundation
Novel Mechanisms & Emerging Therapeutic Modalities
9:30 AM - 10:00 AM
EDT
Coffee & Networking Break
9:30 AM - 10:00 AM
EDT
Coffee & Networking Break
10:00 AM - 11:30 AM
EDT
Symposium 1: Where Are We Now in Pediatric Cancer Drug Development: 5 Years of the RACE for Children Act
Faculty:
Sarah Leary, MD, MS (she/her/hers)
– Seattle Children's & Univ of Washington School of Medicine
Faculty:
Chunze Li, PhD
– Genentech Inc
Specific Populations/Rare Diseases
CE: 1.5
10:00 AM - 11:30 AM
EDT
Symposium 1: Where Are We Now in Pediatric Cancer Drug Development: 5 Years of the RACE for Children Act
Faculty:
Sarah Leary, MD, MS (she/her/hers)
– Seattle Children's & Univ of Washington School of Medicine
Faculty:
Chunze Li, PhD
– Genentech Inc
Specific Populations/Rare Diseases
CE: 1.5
10:00 AM - 11:30 AM
EDT
1 - Regulatory Landscape for Pediatric Cancer Drug Development & the Research to Accelerate Cures & Equity for Children Act
Specific Populations/Rare Diseases
10:00 AM - 11:30 AM
EDT
2 - Pitfalls in Pediatric Study Plans & Determining the Relevance of Specific Molecular Targets for Pediatric Cancers
Specific Populations/Rare Diseases
10:00 AM - 11:30 AM
EDT
3 - Clinical Pharmacology & Modeling & Simulation in Enabling & Accelerating Oncology Drug Development for Pediatrics
Faculty:
Chunze Li, PhD
– Genentech Inc
Specific Populations/Rare Diseases
10:00 AM - 11:30 AM
EDT
4 - Real World Evidence: Clinicians Journey & Bringing Innovation to Pediatric Oncology Development
Faculty:
Sarah Leary, MD, MS (she/her/hers)
– Seattle Children's & Univ of Washington School of Medicine
Specific Populations/Rare Diseases
10:00 AM - 11:30 AM
EDT
5 - Discussion, Questions & Answers, Learner Feedback & Evaluation
Specific Populations/Rare Diseases
10:00 AM - 11:30 AM
EDT
Symposium 2: HOT TOPIC: Current & Next Generation of GLP-1 Receptor Agonists & Obesity Drugs: Overcoming Clinical Pharmacology Challenges
Chair & Faculty:
Sabina Paglialunga, PhD
– Celerion Inc
Faculty:
Anil Kane, PhD, MBA
– Thermo Fisher Scientific Inc
Faculty:
Carolina Säll, PhD
– Novo Nordisk A/S
Faculty:
Aernout van Haarst, PhD
– Celerion Inc
Novel Mechanisms & Emerging Therapeutic Modalities
CE: 1.5
10:00 AM - 11:30 AM
EDT
Symposium 2: HOT TOPIC: Current & Next Generation of GLP-1 Receptor Agonists & Obesity Drugs: Overcoming Clinical Pharmacology Challenges
Chair & Faculty:
Sabina Paglialunga, PhD
– Celerion Inc
Faculty:
Anil Kane, PhD, MBA
– Thermo Fisher Scientific Inc
Faculty:
Carolina Säll, PhD
– Novo Nordisk A/S
Faculty:
Aernout van Haarst, PhD
– Celerion Inc
Novel Mechanisms & Emerging Therapeutic Modalities
CE: 1.5
10:00 AM - 11:30 AM
EDT
1 - A Risk-based Approach to Therapeutic Peptide Drug Development: When to Consider Drug-Drug Interaction Studies
Faculty:
Carolina Säll, PhD
– Novo Nordisk A/S
Novel Mechanisms & Emerging Therapeutic Modalities
10:00 AM - 11:30 AM
EDT
2 - Clinical Pharmacology Considerations for GLP-1 Analog-induced Delayed Gastric Emptying
Faculty:
Aernout van Haarst, PhD
– Celerion Inc
Novel Mechanisms & Emerging Therapeutic Modalities
10:00 AM - 11:30 AM
EDT
3 - Unlocking the Potential of Oral Delivery of Peptides: Improving Oral GLP-1 Bioavailability
Faculty:
Anil Kane, PhD, MBA
– Thermo Fisher Scientific Inc
Novel Mechanisms & Emerging Therapeutic Modalities
10:00 AM - 11:30 AM
EDT
4 - GLP-1 & Beyond: Promising New Targets in the Obesity Drug Pipeline
Faculty:
Sabina Paglialunga, PhD
– Celerion Inc
Novel Mechanisms & Emerging Therapeutic Modalities
10:00 AM - 11:30 AM
EDT
5 - Discussion, Questions & Answers, Learner Feedback & Evaluation
Novel Mechanisms & Emerging Therapeutic Modalities
11:30 AM - 1:30 PM
EDT
Lunch Buffet
11:30 AM - 1:30 PM
EDT
Lunch Buffet
11:45 AM - 1:15 PM
EDT
Lunch & Awards
11:45 AM - 1:15 PM
EDT
Lunch & Awards
1:30 PM - 3:00 PM
EDT
STEP & ESP Panel Discussion & Career Guidance
1:30 PM - 3:00 PM
EDT
STEP & ESP Panel Discussion & Career Guidance
1:30 PM - 5:00 PM
EDT
Symposium 3: Sustainability in the Research & Development of Medicines: An Opportunity for Clinical Pharmacology
Co-Chair & Faculty:
Qi Liu, PhD
– US Food & Drug Administration
Co-Chair & Faculty:
Karthik Venkatakrishnan, PhD
– EMD Serono
Faculty:
Kerry Culm, PhD
– ModeX Therapeutics Inc
Faculty:
Amelia N N. Deitchman, PharmD, PhD
– Univ of California San Francisco
Faculty:
Vaishali Sahasrabudhe, PhD
– Pfizer Inc
Faculty:
Piet H. van der Graaf, PharmD, PhD
– Certara Inc
Innovative Clinical Pharmacology Strategies for Dose Optimization/Model-Informed Drug Development
CE: 3.0
1:30 PM - 5:00 PM
EDT
Symposium 3: Sustainability in the Research & Development of Medicines: An Opportunity for Clinical Pharmacology
Co-Chair & Faculty:
Qi Liu, PhD
– US Food & Drug Administration
Co-Chair & Faculty:
Karthik Venkatakrishnan, PhD
– EMD Serono
Faculty:
Kerry Culm, PhD
– ModeX Therapeutics Inc
Faculty:
Amelia N N. Deitchman, PharmD, PhD
– Univ of California San Francisco
Faculty:
Vaishali Sahasrabudhe, PhD
– Pfizer Inc
Faculty:
Piet H. van der Graaf, PharmD, PhD
– Certara Inc
Innovative Clinical Pharmacology Strategies for Dose Optimization/Model-Informed Drug Development
CE: 3.0
1:30 PM - 5:00 PM
EDT
1 - Sustainability in Pharmaceutical R&D: An Opportunity for Clinical Pharmacology
Co-Chair & Faculty:
Karthik Venkatakrishnan, PhD
– EMD Serono
Innovative Clinical Pharmacology Strategies for Dose Optimization/Model-Informed Drug Development
1:30 PM - 5:00 PM
EDT
2 - Regulatory Initiatives & Frameworks for Driving Efficient & Sustainable Drug Development
Co-Chair & Faculty:
Qi Liu, PhD
– US Food & Drug Administration
Innovative Clinical Pharmacology Strategies for Dose Optimization/Model-Informed Drug Development
1:30 PM - 5:00 PM
EDT
3 - Leveraging Quantitative Translation via QSP for Sustainable Translation in Early Clinical Development: A Case Study in Immuno-Oncology
Faculty:
Kerry Culm, PhD
– ModeX Therapeutics Inc
Innovative Clinical Pharmacology Strategies for Dose Optimization/Model-Informed Drug Development
1:30 PM - 5:00 PM
EDT
4 - Presentation 4
Faculty:
Piet H. van der Graaf, PharmD, PhD
– Certara Inc
Innovative Clinical Pharmacology Strategies for Dose Optimization/Model-Informed Drug Development
1:30 PM - 5:00 PM
EDT
5 - Presentation 5
Faculty:
Amelia N. Deitchman, PharmD, PhD
– Univ of California, San Francisco
Innovative Clinical Pharmacology Strategies for Dose Optimization/Model-Informed Drug Development
1:30 PM - 5:00 PM
EDT
6 - Presentation 6
Faculty:
Vaishali Sahasrabudhe, PhD
– Pfizer Inc
Innovative Clinical Pharmacology Strategies for Dose Optimization/Model-Informed Drug Development
1:30 PM - 5:00 PM
EDT
7 - Discussion, Questions & Answers, Learner Feedback & Evaluation
Innovative Clinical Pharmacology Strategies for Dose Optimization/Model-Informed Drug Development
3:00 PM - 3:30 PM
EDT
Coffee & Networking Break
3:00 PM - 3:30 PM
EDT
Coffee & Networking Break
3:00 PM - 5:00 PM
EDT
STEP & ESP Networking Reception
3:00 PM - 5:00 PM
EDT
STEP & ESP Networking Reception
5:00 PM - 7:00 PM
EDT
Opening Reception, Exhibits & Poster Session 1
5:00 PM - 7:00 PM
EDT
Opening Reception, Exhibits & Poster Session 1